Financial Performance - The company reported a significant increase in revenue, with a year-on-year growth of 15% in 2023[19]. - The net profit for the year reached 150 million CNY, representing a 20% increase compared to the previous year[19]. - The company's operating revenue for 2023 reached ¥949,532,672.96, representing a 16.45% increase compared to ¥815,419,867.85 in 2022[24]. - Net profit attributable to shareholders for 2023 was ¥125,697,377.39, a 10.41% increase from ¥113,842,380.06 in 2022[24]. - The total assets at the end of 2023 amounted to ¥1,879,143,520.60, reflecting a 12.66% increase from ¥1,667,923,982.82 at the end of 2022[24]. - The basic earnings per share for 2023 was ¥0.3350, a 9.55% increase from ¥0.3058 in 2022[24]. - The total revenue for 2023 reached CNY 949,532,672, representing a year-on-year increase of 46.86% compared to CNY 504,564,071 in 2022[79]. - The company reported a total revenue of 1,003 million RMB for the fiscal year 2023, reflecting a year-on-year increase of 10%[140]. - The net profit attributable to shareholders was 669 million RMB, representing a growth of 15% compared to the previous year[140]. Market Expansion and Growth Strategy - The company is focusing on expanding its market presence, targeting a 30% growth in new regions in 2024[19]. - Future guidance indicates an expected revenue growth of 18% for 2024, driven by increased demand in the testing sector[19]. - The company plans to expand its market presence by entering new regions, targeting a 20% increase in market share over the next two years[140]. - The company is expanding its market presence in Southeast Asia, targeting a 25% increase in market share within the next two years[146]. - The company is exploring potential mergers and acquisitions to strengthen its market position and expand its service capabilities[19]. - A strategic acquisition of a local competitor was announced, valued at 200 million RMB, aimed at consolidating market position[146]. Research and Development - The company has allocated 10 million CNY for research and development in new technologies for the upcoming year[19]. - The company authorized 56 patents and published 42 standards in 2023, with 22 of them being led in formulation or revision[61]. - Research and development expenses for 2023 were CNY 102,610,908.61, a slight increase of 1.26% from CNY 101,337,128.39 in 2022[85]. - The number of R&D personnel increased by 38.03% to 196 in 2023, with a higher proportion of staff holding master's degrees, rising by 66.67%[86]. - The company is developing several new technologies, including a high-precision measurement system for high-temperature irregular workpieces, expected to enhance economic benefits and core competitiveness[86]. - The company plans to launch three new products in the next fiscal year, which are expected to contribute an additional 5% to overall revenue[140]. - The company’s new product developments included high-end scientific instruments, with significant sales achievements in plasma mass spectrometers and scanning electron microscopes[72]. Operational Efficiency and Cost Management - The company plans to implement cost control measures and lean management to reduce expenses and improve efficiency[111]. - The company aims to reduce operational costs by 5% through efficiency improvements in the next fiscal year[146]. - The company has implemented a new operational strategy focusing on efficiency improvements, aiming to reduce operational costs by 5%[140]. - The company maintains a cost-plus pricing strategy for its services and products, ensuring profitability while considering market conditions and production costs[51]. Governance and Compliance - The company has established a governance structure that ensures clear responsibilities among the board, supervisory board, and management[130]. - The board consists of 7 members, including 3 independent directors, complying with legal requirements[132]. - The company has maintained independence from its controlling shareholder in terms of operations, personnel, assets, and finances[136]. - The company has implemented a "Quality Return Double Improvement" action plan[128]. - The company strictly adheres to information disclosure regulations, ensuring timely and accurate information for investors[135]. - The company has established specialized committees under the board, including an audit committee and a strategic committee, to enhance governance[132]. Employee Management and Development - The company reported a total of 1,288 employees at the end of the reporting period, with 679 in the parent company and 609 in major subsidiaries[165]. - The employee composition includes 622 production personnel, 229 sales personnel, 196 technical personnel, 30 financial personnel, and 211 administrative personnel[165]. - The company has a total of 34 PhD holders, 300 master's degree holders, 624 bachelor's degree holders, 204 associate degree holders, and 126 individuals with education below associate degree[165]. - The company conducts both internal and external training programs to enhance employee skills and safety awareness[168]. - The company has established a comprehensive salary management system, focusing on performance and market competitiveness[166]. Risks and Challenges - The management highlighted potential risks in the market, including regulatory changes and competition, which could impact future performance[5]. - The company faces intensified competition in the testing industry, with a low industry concentration and increasing pressure from international firms entering the market through various means, which could adversely affect its operational performance[117]. - The company acknowledges the risk of operational performance fluctuations due to external economic challenges and intensified market competition, and plans to enhance its core competitiveness to mitigate these risks[125]. - Continuous technological innovation is crucial; failure to keep pace with market demands may weaken the company's competitive advantage and affect its market share and performance[119]. Dividend and Profit Distribution - The company plans to distribute a cash dividend of 1.00 CNY per 10 shares (including tax) based on a total of 383,175,000 shares[5]. - The proposed cash dividend is 1.00 CNY per 10 shares (before tax), totaling 38,317,500 CNY, which represents 30.48% of the net profit attributable to shareholders and 36.67% of the parent company's net profit[173]. - The company has a profit distribution plan that aligns with its articles of association and dividend management policies, ensuring compliance with regulations[171]. - The cash dividend distribution plan is designed to provide stable and reasonable returns to investors while considering the company's long-term development[173].

钢研纳克检测技术股份有限公司 控股股东及其他关联方资金占用情况的 专项说明 大华核字[2024]0011001108 号 大 华 会 计 师 事 务 所 (特 殊 普 通 合 伙 ) Da Hua Certified Public Accountants（Special General Partnership） 钢研纳克检测技术股份有限公司 控股股东及其他关联方资金占用情况的专项说明 二、 钢研纳克检测技术股份有限公司 2023 年度非 经营性资金占用及其他关联资金往来情况汇 总表 1-3 （截止 2023 年 12 月 31 日） 目 录 页 次 一、 控股股东及其他关联方资金占用情况的专项 说明 1-2 大华会计师事务所（特殊普通合伙） 北京市海淀区西四环中路 16 号院 7 号楼 12 层 [100039] 电话：86 (10) 5835 0011 传真：86 (10) 5835 0006 www.dahua-cpa.com 控 股 股 东 及 其 他 关 联 方 资 金 占 用 情 况 的 专 项 说 明 大华核字[2024]0011001108 号 钢研纳克检测技术股份有限公司全体股东： 我们接受委 ...

Financial Performance - The company reported a significant increase in revenue, with a year-on-year growth of 15% in 2023[19]. - The company's operating revenue for 2023 was CNY 949,532,672.96, representing a 16.45% increase compared to CNY 815,419,867.85 in 2022[24]. - The net profit attributable to shareholders for 2023 was CNY 125,697,377.39, a 10.41% increase from CNY 113,842,380.06 in 2022[24]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was CNY 103,127,521.28, up 27.87% from CNY 80,647,992.72 in 2022[24]. - The total assets at the end of 2023 were CNY 1,879,143,520.60, reflecting a 12.66% increase from CNY 1,667,923,982.82 at the end of 2022[24]. - The basic earnings per share for 2023 was CNY 0.3350, a 9.55% increase from CNY 0.3058 in 2022[24]. - The company reported a total revenue of 1,003 million RMB for the fiscal year 2023, reflecting a year-on-year increase of 10%[140]. - The company reported a total revenue of 3,997 million in 2022, an increase from 2,195 million in 2021, reflecting a growth of approximately 82.5%[101]. Dividend Policy - The company plans to distribute a cash dividend of 1.00 yuan (including tax) for every 10 shares based on a total of 383,175,000 shares[5]. - The proposed cash dividend is 1.00 CNY per 10 shares, totaling 38,317,500 CNY, which represents 30.48% of the net profit attributable to shareholders and 36.67% of the parent company's net profit[173]. - The company implemented a dividend policy, distributing 0.5 RMB per share to shareholders, reflecting a commitment to returning value to investors[140]. Market Expansion and Strategy - The company is focusing on expanding its market presence, particularly in the Asia-Pacific region, aiming for a 20% increase in market share by 2025[19]. - The company plans to expand its market presence in Southeast Asia, targeting a 25% increase in market share within the next two years[140]. - The company is expanding its market presence in Southeast Asia, targeting a 10% market share by 2025[146]. - A strategic acquisition of a local competitor is under consideration to enhance service capabilities and broaden the product portfolio[140]. - The company has completed a strategic acquisition of a local competitor for 300 million RMB to enhance its service capabilities[146]. Research and Development - The company has invested 10 million yuan in R&D for new product development, targeting the launch of two new testing technologies in 2024[19]. - The company authorized 56 patents and published 42 standards in 2023, demonstrating strong innovation capabilities[61]. - The company has allocated 100 million RMB for research and development in the upcoming year, focusing on advanced materials testing technologies[140]. - The company’s R&D expenses for 2023 were CNY 102,610,908.61, a slight increase of 1.26% compared to CNY 101,337,128.39 in 2022[85]. - The number of R&D personnel increased by 38.03% to 196 in 2023, with a higher proportion of personnel holding master's degrees[86]. - The company is developing several new technologies, including a high-precision measurement system for high-temperature irregular workpieces, expected to enhance economic benefits[86]. Customer Engagement and Satisfaction - User data indicates a 25% increase in customer engagement through digital platforms in 2023[19]. - The company is implementing new strategies to enhance customer satisfaction, aiming for a 90% satisfaction rate by the end of 2024[19]. - The number of users increased by 20% compared to the previous year, reaching a total of 500,000 active users[140]. - User data indicates an increase in active clients by 25%, reaching a total of 500,000 users[146]. Operational Efficiency - The company achieved a net profit margin of 12% in 2023, reflecting improved operational efficiency[19]. - The gross margin for third-party testing services was 50.63%, reflecting an increase of 2.38% compared to the previous year[78]. - The company maintains a cost-plus pricing strategy for its services and products, ensuring profitability while considering market conditions and production costs[51]. - The company’s financial expenses decreased significantly by 39.94% to CNY 3,218,435.12, indicating improved financial management[85]. Risk Management - The company has identified potential risks in its future operations, including regulatory changes and market competition, which are detailed in the management discussion section[5]. - The company recognizes risks related to brand reputation and social credibility, which are critical for its long-term sustainability[116]. - The company faces intensified competition in the testing industry, with many international firms entering the market, which could adversely affect its operating performance if it does not enhance technological and management innovation[117]. - The company is closely monitoring external economic conditions and is prepared to implement measures to enhance its core competitiveness in response to market fluctuations[125]. Governance and Management - The company has established a governance structure that ensures clear responsibilities among the board, supervisory board, and management[130]. - The board consists of 7 members, including 3 independent directors, complying with legal requirements[132]. - The company maintains independence from its controlling shareholder in terms of operations, assets, and finances[136]. - The company has a comprehensive remuneration decision-making process based on performance and responsibilities[153]. - The company has established a strong governance structure with independent directors overseeing operations[151]. Employee Development - The company emphasizes talent development to build a competitive workforce for sustainable growth[114]. - The company conducts both internal and external training programs to enhance employee skills and safety awareness[168]. - The employee composition includes 622 production personnel, 229 sales personnel, 196 technical personnel, 30 financial personnel, and 211 administrative personnel[165]. Compliance and Internal Control - The company established a comprehensive internal control system to ensure the authenticity and completeness of financial information, including the formulation of 10 internal audit regulations[199]. - The company has not reported any significant internal control deficiencies during the reporting period, indicating effective governance practices[200]. - The company adheres to strict information disclosure practices, ensuring timely and accurate information is available to all investors[135]. Future Projections - The company expects a revenue growth guidance of 15% for the next fiscal year, projecting revenues to reach approximately 1,153 million RMB[140]. - The company has projected a revenue growth of 20% for the next fiscal year, aiming for 1.44 billion RMB[146]. - The management team has set a goal to achieve a net profit margin of 12% by the end of 2024, up from 10% in 2023[146].

证券代码：300797 证券简称：钢研纳克 公告编号：2024-013 钢研纳克检测技术股份有限公司 关于《钢研纳克检测技术股份有限公司控股股东及其他关联方资金占用情况的 专项说明》的更正公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假记载、 误导性陈述或重大遗漏。 | 非经营性 | 资金占用方名称 | 占用方与上 市公司 | 上市公司核 算的会计科 | 2023 占用资金余 | 年期初 | 2023 年度占 用累计发生 | 2023 用资金的利 | 年度占 | 2023 还累计发生 | 年度偿 | 2023 年期末 占用资金余 | | 占用形成原 | 占用性质 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 资金占用 | | | | | | 金额（不含 | | | | | | | 因 | | | | 安泰科技股份有限 | 的关联关系 实际控制人 | 目 | 额 | | 利息） | | 息（如有） | 金额 | | 额 | | | | | | ...

Investment Rating - The report maintains a "Buy" rating for the company [4][18]. Core Views - The company has achieved a revenue of 950 million yuan in 2023, representing a year-on-year growth of 16%, with a net profit of 126 million yuan, up 10% year-on-year [14]. - The third-party testing business has seen a revenue increase of 25% to 483 million yuan, driving overall revenue growth [14]. - The company is expanding its national layout of testing laboratories, with several locations already operational and others under renovation [14]. - The sales of high-end scientific instruments have increased, with new products like mass spectrometers and electron microscopes gaining recognition in the market [2][24]. Summary by Sections Financial Performance - In 2023, the company achieved an operating income of 950 million yuan, a 16% increase year-on-year, and a net profit of 126 million yuan, a 10% increase year-on-year [14]. - The third-party testing business contributed 483 million yuan in revenue, marking a 25% increase [14]. - The company’s gross profit margin for the third-party testing business improved to 50.63%, up 2.38% year-on-year [1]. Business Development - The company is transitioning its third-party testing services towards high-barrier material evaluation, providing comprehensive testing and evaluation services for national major engineering projects [1]. - The company has secured 55 national-level projects from various government departments [1]. - The sales of basic testing instruments have reached record highs, with products like ICP spectrometers and gas element analyzers achieving significant sales [24]. Future Outlook - The report forecasts net profits for 2024, 2025, and 2026 to be 172 million yuan, 194 million yuan, and 244 million yuan respectively, with corresponding EPS of 0.45, 0.51, and 0.64 yuan [18]. - The company aims for a compound annual growth rate of over 17% in net profit during the "14th Five-Year Plan" period [15].

证券代码：300797 证券简称：钢研纳克 公告编号：2024-004 钢研纳克检测技术股份有限公司 关于提请股东大会授权董事会办理以简易程序发行向特定对象发行股票的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假记载、 误导性陈述或重大遗漏。 2024 年 4 月 17 日，钢研纳克检测技术股份有限公司（以下简称"公司"）召开第二届 董事会第二十四次会议，审议通过了《关于钢研纳克检测技术股份有限公司提请股东大会授 权董事会办理以简易程序向特定对象发行股票的议案》，同意董事会提请股东大会授权董事 会办理公司以简易程序发行向特定对象发行融资总额不超过人民币 3 亿元且不超过最近一 年末净资产 20%的股票（以下简称："本次发行"），授权期限自公司 2023 年年度股东大会审 议通过之日起至公司 2024 年年度股东大会召开之日止。上述事项尚需公司 2023 年年度股 东大会审议通过。 一、本次发行的具体内容 1、发行证券的种类和数量 向特定对象发行融资总额不超过人民币三亿元且不超过最近一年末净资产百分之二十 的人民币普通股（A 股）。发行数量按照募集资金总额除以发行价格确定，不超过发行前 ...

钢研纳克检测技术股份有限公司 审计报告 大华审字[2024]0011000157 号 大 华 会 计 师 事 务 所 (特 殊 普 通 合 伙 ) DaHuaCertifiedPublicAccountants（SpecialGeneralPartnership） 钢研纳克检测技术股份有限公司 审计报告及财务报表 （2023 年 1 月 1 日至 2023 年 12 月 31 日止） | | 目录 | 页次 | | --- | --- | --- | | 一、 | 审计报告 | 1-5 | | 二、 | 已审财务报表 | | | | 合并资产负债表 | 1-2 | | | 合并利润表 | 3 | | | 合并现金流量表 | 4 | | | 合并股东权益变动表 | 5-6 | | | 母公司资产负债表 | 7-8 | | | 母公司利润表 | 9 | | | 母公司现金流量表 | 10 | | | 母公司股东权益变动表 | 11-12 | | | 财务报表附注 | 1-109 | | 合并资产负债表 | | | | | --- | --- | --- | --- | | 2023年12月31日 | | | | ...

钢研纳克检测技术股份有限公司 内部控制审计报告 大华内字[2024]0011000418 号 大 华 会 计 师 事 务 所 (特 殊 普 通 合 伙 ) Da Hua Certified Public Accountants（Special General Partnership） 钢研纳克检测技术股份有限公司 内部控制审计报告 （截止 2023 年 12 月 31 日） 1-2 内 部 控 制 审 计 报 告 目 录 页 次 一、 内部控制审计报告 内部控制具有固有局限性，存在不能防止和发现错报的可能性。 此外，由于情况的变化可能导致内部控制变得不恰当，或对控制政策 和程序遵循的程度降低，根据内部控制审计结果推测未来内部控制的 有效性具有一定风险。 四、财务报告内部控制审计意见 大华内字【2024】0011000418 号内部控制审计报告 我们认为，钢研纳克于 2023 年 12 月 31 日按照《企业内部控制 基本规范》和相关规定在所有重大方面保持了有效的财务报告内部控 制。 大华内字[2024]0011000418 号 钢研纳克检测技术股份有限公司全体股东： 按照《企业内部控制审计指引》及中国注册会计 ...

2023 年度，公司共计召开 6 次董事会，审议 38 项议案，本人均 亲自出席，没有缺席会议情况；2023 年度，公司共计召开 4 次股东大 会，本人作为独立董事均出席了会议。 本着勤勉务实和诚信负责的原则，本人在召开董事会前主动获取 做出决策所需要的相关资料，并全面了解公司运营情况，以便为董事 会重要决策做好前期的准备工作；会上积极参与讨论并提出意见，以 谨慎的态度行使表决权。日常工作中持续关注议案实施情况，充分发 挥了董事的监督制衡作用。本人认为 2023 年度任职期间公司董事会 会议的召集召开程序合法合规，重大经营事项均履行了相关审批程序， 合法有效，均未损害全体股东，特别是中小股东的利益。因此，本人 对所有非回避议案均投出了赞成票，无提出异议事项，没有反对、弃 权的情况。在股东大会期间，认真听取了股东意见和建议。 钢研纳克检测技术股份有限公司独立董事 2023 年度述职报告 张晓维 各位股东： 本人作为钢研纳克检测技术股份有限公司（以下简称"公司"） 的独立董事，在任职期间严格按照《公司法》《证券法》《深圳证券交 易所创业板股票上市规则》《上市公司独立董事管理办法》等法律、 法规和《公司章程》《董事 ...

2023 年度，公司共计召开 6 次董事会，审议 38 项议案，本人均 亲自出席，没有缺席会议情况；2023 年度，公司共计召开 4 次股东 大会，本人作为独立董事均出席了会议。 本着勤勉务实和诚信负责的原则，本人在召开董事会前主动获取 做出决策所需要的相关资料，并全面了解公司运营情况，以便为董事 会重要决策做好前期的准备工作；会上积极参与讨论并提出意见，以 谨慎的态度行使表决权。日常工作中持续关注议案实施情况，充分发 钢研纳克检测技术股份有限公司独立董事 2023 年度述职报告 夏宁 各位股东： 本人作为钢研纳克检测技术股份有限公司（以下简称"公司"） 的独立董事，在任职期间严格按照《公司法》《证券法》《深圳证券交 易所创业板股票上市规则》《上市公司独立董事管理办法》等法律、 法规和《公司章程》《董事会议事规则》《独立董事制度》等规定，认 真履行职责，充分发挥董事的作用，恪尽职守，勤勉尽责，维护公司 利益，维护全体股东利益，履行了董事职责，谨慎、认真、勤勉地行 使法律法规所赋予的权利，积极出席相关会议，对各项议案进行认真 审议，充分发挥了董事及各专门委员会委员的作用。现就本人 2023 年度的履职情况报告如 ...